Bertrand Loy has bought stock on 6 days since Sep 2019
Exec Chair at Entegris, Inc., and 1 other company
SEC CIK 0001197452 · Filings on SEC.gov ↗
Bertrand Loy's record
3 months after each buy, from the first price a copier could get.
4 buys since 2019 with 3 months of prices.
Companies
Every filing
19 filings since Feb 2018, newest first
Entegris Inc
Exec Chair
Entegris Inc
Exec Chair
Entegris Inc
Exec Chair
Entegris Inc
Exec Chair
Entegris Inc
President and CEO
Harvard Bioscience Inc
Director
Harvard Bioscience Inc
Director
Harvard Bioscience Inc
Director
Harvard Bioscience Inc
Director
Entegris Inc
President and CEO
Entegris Inc
President and CEO
Entegris Inc
President and CEO
Entegris Inc
President and CEO
Entegris Inc
President and CEO
Entegris Inc
President and CEO
Entegris Inc
President and CEO
Harvard Bioscience Inc
Director
Harvard Bioscience Inc
Director
Entegris Inc
President and CEO
About Bertrand Loy
Bertrand Loy is a seasoned executive who joined Entegris, Inc. (NASDAQ: ENTG) in August 2005 through the merger with Mykrolis, where he served as Chief Financial Officer since 2001.( His career at Entegris progressed through key roles including Senior Vice President of Global Supply Chain and Manufacturing, Chief Operating Officer, and President and CEO from November 2012 until his retirement from those positions on August 18, 2025.( Loy holds an MBA from ESSEC Business School and a Bachelor of Science in Business Administration from the University of Paris-Dauphine, complemented by a TGMP from Harvard Business School.(
Currently serving as Executive Chair of the Entegris Board of Directors through the end of Q2 2026 to support the transition to new CEO David Reeder, Loy has driven significant growth, expanding Entegris' global footprint, technology portfolio, and shareholder value over two decades.( Prior roles include positions at Millipore Corporation (1995-2001) and W.R. Grace & Co. (1988-1995), along with board directorships at companies like Harvard Bioscience and ATMI.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.